FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221052410> ?p ?o ?g. }

• W4221052410 abstract "Abstract Objectives The rapid spread of the Omicron variant (B.1.1.529) alongside evidence of a relatively rapid waning of the third dose prompted Israel to administer a fourth dose of the BNT162b2 vaccine on January 2022. Thus far, sufficient real-world evidence demonstrating the effectiveness of a fourth dose against infection and severe COVID-19 are lacking. This study examined the short-term effectiveness of a fourth dose compared to three doses over the span of 10 weeks. Design A retrospective test-negative case-control study, performing both a matched analysis and an unmatched multiple-tests analysis. Setting Nationally centralized database of Maccabi Healthcare Services (MHS), an Israeli national health fund that covers 2.5 million people. Participants The study population included 97,499 MHS members aged 60 or older who were eligible to receive a fourth vaccine dose and performed at least one PCR test during the study period. Of them, 27,876 received the fourth dose and 69,623 received only three doses. Main outcomes and measures Analyses focused on the period from January 10, 2022 (7 days after the fourth dose was first administered to eligible individuals) to March 13, 2022, an Omicron-dominant period in Israel. We evaluated two SARS-CoV-2-related outcomes: (1) breakthrough infection, defined as a positive PCR test performed 7 or more days after inoculation with the BNT162b2 vaccine; and (2) breakthrough infection resulting in a severe disease, defined as COVID-19-related hospitalization or COVID-19 associated mortality. Results A fourth dose provided considerable additional protection against both SARS-CoV-2 infection and severe disease relative to three doses of the vaccine. However, vaccine effectiveness against infection varied over time, peaking during the third week with a VE of 64% (95% CI: 62.0%-65.9%) and declining to 29.2% (95% CI: 17.7%-39.1%) by the end of the 10-week follow-up period. Unlike VE against infection, the relative effectiveness of a fourth dose against severe COVID-19 was maintained at high level (>73%) throughout the 9-week follow-up period. Importantly, severe disease was a relatively rare event, occurring in <1% of both fourth dose and third dose only recipients. Conclusions A fourth dose of the BNT162b2 vaccine provided considerable additional protection against both SARS-CoV-2 infection and severe disease relative to three doses of the vaccine. However, effectiveness of the fourth dose against infection wanes sooner than that of the third dose." @default.
• W4221052410 created "2022-04-03" @default.
• W4221052410 creator A5033591948 @default.
• W4221052410 creator A5034265331 @default.
• W4221052410 creator A5035073544 @default.
• W4221052410 creator A5048336058 @default.
• W4221052410 creator A5076126189 @default.
• W4221052410 creator A5090120637 @default.
• W4221052410 date "2022-03-24" @default.
• W4221052410 modified "2023-09-27" @default.
• W4221052410 title "Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel" @default.
• W4221052410 cites W1963641435 @default.
• W4221052410 cites W1981055539 @default.
• W4221052410 cites W2101831741 @default.
• W4221052410 cites W2162124703 @default.
• W4221052410 cites W2170034816 @default.
• W4221052410 cites W3093667122 @default.
• W4221052410 cites W3120392574 @default.
• W4221052410 cites W3123366914 @default.
• W4221052410 cites W3131688063 @default.
• W4221052410 cites W3157162195 @default.
• W4221052410 cites W3180026249 @default.
• W4221052410 cites W3180511106 @default.
• W4221052410 cites W3195990721 @default.
• W4221052410 cites W3196352038 @default.
• W4221052410 cites W3197637869 @default.
• W4221052410 cites W3216645551 @default.
• W4221052410 cites W4210362857 @default.
• W4221052410 cites W4210862829 @default.
• W4221052410 cites W4214701692 @default.
• W4221052410 cites W4220922192 @default.
• W4221052410 cites W4220990517 @default.
• W4221052410 doi "https://doi.org/10.1101/2022.03.24.22272835" @default.
• W4221052410 hasPublicationYear "2022" @default.
• W4221052410 type Work @default.
• W4221052410 citedByCount "8" @default.
• W4221052410 countsByYear W42210524102022 @default.
• W4221052410 countsByYear W42210524102023 @default.
• W4221052410 crossrefType "posted-content" @default.
• W4221052410 hasAuthorship W4221052410A5033591948 @default.
• W4221052410 hasAuthorship W4221052410A5034265331 @default.
• W4221052410 hasAuthorship W4221052410A5035073544 @default.
• W4221052410 hasAuthorship W4221052410A5048336058 @default.
• W4221052410 hasAuthorship W4221052410A5076126189 @default.
• W4221052410 hasAuthorship W4221052410A5090120637 @default.
• W4221052410 hasBestOaLocation W42210524101 @default.
• W4221052410 hasConcept C126322002 @default.
• W4221052410 hasConcept C151730666 @default.
• W4221052410 hasConcept C187212893 @default.
• W4221052410 hasConcept C2777267654 @default.
• W4221052410 hasConcept C2779134260 @default.
• W4221052410 hasConcept C2908647359 @default.
• W4221052410 hasConcept C3007834351 @default.
• W4221052410 hasConcept C3008058167 @default.
• W4221052410 hasConcept C3018095205 @default.
• W4221052410 hasConcept C524204448 @default.
• W4221052410 hasConcept C71924100 @default.
• W4221052410 hasConcept C86803240 @default.
• W4221052410 hasConcept C99454951 @default.
• W4221052410 hasConceptScore W4221052410C126322002 @default.
• W4221052410 hasConceptScore W4221052410C151730666 @default.
• W4221052410 hasConceptScore W4221052410C187212893 @default.
• W4221052410 hasConceptScore W4221052410C2777267654 @default.
• W4221052410 hasConceptScore W4221052410C2779134260 @default.
• W4221052410 hasConceptScore W4221052410C2908647359 @default.
• W4221052410 hasConceptScore W4221052410C3007834351 @default.
• W4221052410 hasConceptScore W4221052410C3008058167 @default.
• W4221052410 hasConceptScore W4221052410C3018095205 @default.
• W4221052410 hasConceptScore W4221052410C524204448 @default.
• W4221052410 hasConceptScore W4221052410C71924100 @default.
• W4221052410 hasConceptScore W4221052410C86803240 @default.
• W4221052410 hasConceptScore W4221052410C99454951 @default.
• W4221052410 hasLocation W42210524101 @default.
• W4221052410 hasOpenAccess W4221052410 @default.
• W4221052410 hasPrimaryLocation W42210524101 @default.
• W4221052410 hasRelatedWork W3162081874 @default.
• W4221052410 hasRelatedWork W3176864053 @default.
• W4221052410 hasRelatedWork W3198183218 @default.
• W4221052410 hasRelatedWork W4205317059 @default.
• W4221052410 hasRelatedWork W4205810683 @default.
• W4221052410 hasRelatedWork W4206669628 @default.
• W4221052410 hasRelatedWork W4224279380 @default.
• W4221052410 hasRelatedWork W4308496516 @default.
• W4221052410 hasRelatedWork W4311787753 @default.
• W4221052410 hasRelatedWork W4313020900 @default.
• W4221052410 isParatext "false" @default.
• W4221052410 isRetracted "false" @default.
• W4221052410 workType "article" @default.